Standard Operating Procedure for Regulatory Review of Mock-Ups and Specimens
| Department | Regulatory Affairs |
| SOP No. | RA/2026/760 |
| Supersedes | NA |
| Page No. | 1 of X |
| Issue Date | 16/04/2026 |
| Effective Date | 16/04/2026 |
| Review Date | 16/04/2028 |
Purpose
This Standard Operating Procedure (SOP) establishes a systematic and controlled process for the regulatory review of mock-ups and specimens used in labelling, artwork, and product information within the pharmaceutical environment. The purpose is to ensure accuracy, compliance with regulatory requirements, adherence to internal quality standards, and timely approval of all mock-ups and specimens prior to their use or submission. This SOP supports the control objective of minimizing regulatory risks and ensuring that product information is consistent, accurate, and aligned with current regulatory guidelines.
Scope
This SOP applies to all departments and functional areas involved in the creation, review, approval, or management of mock-ups and specimens related to pharmaceutical labelling, artwork, and product information control. It encompasses review activities for all dosage forms, packaging types, label formats, and artwork designs intended for local and global regulatory submissions and commercial use. Activities excluded from this SOP include manufacturing batch release documentation and external vendor quality audits, which are governed by separate SOPs.
Responsibilities
- Regulatory Affairs Team: Execute the regulatory review of mock-ups and specimens in accordance with applicable guidelines and this SOP.
- Quality Assurance: Oversee the compliance of the review process and perform independent verification and approvals.
- Document Control: Manage document version control, filing, and archiving of all reviewed mock-ups and specimens.
- Project Management: Coordinate timelines and stakeholder communication to ensure timely review completion.
- Cross-Functional Reviewers: Provide technical, regulatory, quality, and legal input during the review cycle as applicable.
Accountability
The Head of Regulatory Affairs is accountable for the overall implementation, adherence, periodic review, enforcement, and continuous effectiveness of this SOP. This includes escalation of non-compliances and ensuring all regulatory review activities meet internal and external quality standards.
Procedure
The regulatory review of mock-ups and specimens shall be conducted in a structured manner following these stages:
1. Preparation and Prerequisites: Collect all relevant source documents including draft label text, artwork files, product specifications, and applicable regulatory guidelines. Confirm the scope of the review and identify required regulatory jurisdictions.
2. Initial GMP and Compliance Checks: Verify that the mock-up or specimen meets Good Manufacturing Practice (GMP) labelling requirements, such as legibility, correct placement, use of approved fonts, and regulatory disclaimers. Ensure all content complies with the latest approved product information and regulatory submissions.
3. Detailed Regulatory Review Execution: Each reviewer systematically examines text accuracy, graphical elements, barcodes, expiry and batch number fields, and regulatory markings against dossier commitments and country-specific regulations. Any discrepancies or deviations are logged for clarification or correction.
4. Cross-Functional Feedback and Resolution: Compile consolidated comments from all reviewers and communicate with the artwork or labelling team for necessary revisions. Track changes and ensure all modifications are addressed and re-reviewed as necessary.
5. Final Approval and Documentation: Regulatory Affairs and Quality Assurance finalize approval upon satisfactory resolution of comments. Approvals are documented with signatures and date stamps. The final approved mock-up/specimen is version controlled and archived in the document management system.
6. Deviation Handling: Any deviations identified during review or post-approval that impact regulatory compliance must be documented, investigated, and approved through established deviation management procedures before release.
7. Training and Change Management: Ensure all involved personnel are trained on this SOP and any updates. Changes affecting regulatory labelling requirements are communicated promptly to all stakeholders.
8. Record Retention and Closure: Maintain all review records, approvals, correspondence, and version histories for the period specified by internal policies or regulatory requirements. Close the review cycle formally and update applicable tracking systems.
Compliance with this procedure ensures that all regulatory mock-ups and specimens meet required standards prior to market introduction or submission, minimizing risk and aligning with quality and regulatory frameworks.
Abbreviations
- GMP – Good Manufacturing Practice
- RA – Regulatory Affairs
- QA – Quality Assurance
- SOP – Standard Operating Procedure
- QA – Quality Assurance
- DMS – Document Management System
Documents
- Regulatory Review Checklist for Mock-Ups and Specimens (Annexure-1)
- Mock-Up and Specimen Review Log (Annexure-2)
- Approval Form for Regulatory Review of Mock-Ups and Specimens (Annexure-3)
References
- EU Guidelines for Good Manufacturing Practice, Annex 13 – Labeling and Packaging
- ICH Q7 – Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients
- FDA 21 CFR Part 211 – Current Good Manufacturing Practice for Finished Pharmaceuticals
- Internal Quality Management System Documents and Policies
- Pharmaceutical Product Labelling Regulatory Guidelines (Country-specific as applicable)
Version
1.0
Approval
| Prepared By | |
| Checked By | |
| Approved By |
Annexures
Annexure-1: Regulatory Review Checklist for Mock-Ups and Specimens
Purpose: To ensure all critical regulatory, compliance, and quality attributes are systematically verified during the review of a mock-up or specimen.
| Check Item | Verification Status (Yes/No) | Comments |
|---|---|---|
| Correct product name and strength | Yes | Matches approved dossier text |
| Batch number/Expiry date placement verified | Yes | Located as per specifications |
| Regulatory disclaimer included and accurate | Yes | Confirmed per local regulations |
| Barcodes and GTIN correct | Yes | Validated against master data |
| Font type and size compliant with SOP | Yes | Legibility confirmed |
| Artwork elements reflect approved design | Yes | No deviations found |
| Language and translations accurate | Yes | Cross-checked with approved versions |
| Change history reviewed and documented | Yes | All changes dated and authorized |
Annexure-2: Mock-Up and Specimen Review Log
Purpose: To document all review activities, comments, and status updates of the mock-ups and specimens under evaluation.
| Review Date | Reviewer Role | Comments/Findings | Action Taken | Status |
|---|---|---|---|---|
| 10/04/2026 | Regulatory Affairs Reviewer | Minor discrepancy in expiry date font size | Corrected by artwork team | Closed |
| 12/04/2026 | Quality Assurance | No further issues identified | Approved for final review | Closed |
| 15/04/2026 | Regulatory Affairs Lead | Final approval granted | N/A | Closed |
Annexure-3: Approval Form for Regulatory Review of Mock-Ups and Specimens
Purpose: To formally document the approval of the regulatory review of mock-ups and specimens prior to their release or submission.
| Document Name | Mock-Up Label Version 3.1 |
| Reviewed By | Regulatory Affairs Reviewer |
| Date of Review | 15/04/2026 |
| Comments | All criteria met as per checklist; approved without comments. |
| Approved By | Regulatory Affairs Head |
| Date of Approval | 16/04/2026 |
| Signature | _________________________ |
Revision History
| Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
| 16/04/2026 | 1.0 | Initial issue | New SOP creation |